BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24966932)

  • 1. Expression of G protein-coupled estrogen receptor in irritable bowel syndrome and its clinical significance.
    Qin B; Dong L; Guo X; Jiang J; He Y; Wang X; Li L; Zhao J
    Int J Clin Exp Pathol; 2014; 7(5):2238-46. PubMed ID: 24966932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2Y1, P2Y2, and TRPV1 Receptors Are Increased in Diarrhea-Predominant Irritable Bowel Syndrome and P2Y2 Correlates with Abdominal Pain.
    Luo Y; Feng C; Wu J; Wu Y; Liu D; Wu J; Dai F; Zhang J
    Dig Dis Sci; 2016 Oct; 61(10):2878-2886. PubMed ID: 27250983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mRNA expression in ileal and colonic biopsies in irritable bowel syndrome with diarrhea or constipation.
    Camilleri M; Magnus Y; Carlson P; Wang XJ; Chedid V; Maselli D; Taylor A; McKinzie S; Kengunte Nagaraj N; Busciglio I; Nair A
    Am J Physiol Gastrointest Liver Physiol; 2022 Aug; 323(2):G88-G101. PubMed ID: 35502856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR; Xu XJ; Yao SK
    World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen signaling deregulation related with local immune response modulation in irritable bowel syndrome.
    Jacenik D; Cygankiewicz AI; Fichna J; Mokrowiecka A; Małecka-Panas E; Krajewska WM
    Mol Cell Endocrinol; 2018 Aug; 471():89-96. PubMed ID: 28774781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
    Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
    Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M
    Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
    Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
    World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression pattern of estrogen receptors α and β and G-protein-coupled estrogen receptor 1 in the human testis.
    Fietz D; Ratzenböck C; Hartmann K; Raabe O; Kliesch S; Weidner W; Klug J; Bergmann M
    Histochem Cell Biol; 2014 Oct; 142(4):421-32. PubMed ID: 24692005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E
    Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
    Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
    World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Guilarte M; Vicario M; Martínez C; de Torres I; Lobo B; Pigrau M; González-Castro A; Rodiño-Janeiro BK; Salvo-Romero E; Fortea M; Pardo-Camacho C; Antolín M; Saperas E; Azpiroz F; Santos J; Alonso-Cotoner C
    Am J Gastroenterol; 2020 Dec; 115(12):2047-2059. PubMed ID: 32740086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.
    Du C; Peng L; Kou G; Wang P; Lu L; Li Y
    Dig Dis Sci; 2018 May; 63(5):1182-1191. PubMed ID: 29516326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits.
    Miwa J; Echizen H; Matsueda K; Umeda N
    Digestion; 2001; 63(3):188-94. PubMed ID: 11351146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
    Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between adherens junction and tight junction and clinical symptoms in patients with diarrhea predominant irritable bowel syndrome].
    Zhang M; Chen CY; Hu Y; Lyu B
    Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):40-46. PubMed ID: 31887835
    [No Abstract]   [Full Text] [Related]  

  • 19. The expression of protease-activated receptor 2 and 4 in the colon of irritable bowel syndrome patients.
    Zhao JH; Dong L; Shi HT; Wang ZY; Shi HY; Ding H
    Dig Dis Sci; 2012 Jan; 57(1):58-64. PubMed ID: 21800160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPER-mediated, oestrogen-dependent visceral hypersensitivity in stressed rats is associated with mast cell tryptase and histamine expression.
    Xu S; Wang X; Zhao J; Yang S; Dong L; Qin B
    Fundam Clin Pharmacol; 2020 Aug; 34(4):433-443. PubMed ID: 31967341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.